EPIX ESSA Pharma
- 1.765
- +0.005+0.28%
ESSA Pharma News
Bloom Burton Downgrades ESSA Pharma(EPIX.US) to Hold Rating, Cuts Target Price to $2.25
ESSA Pharma Analyst Ratings
Essa Pharma Price Target Cut to $2.00/Share From $15.00 by Piper Sandler
Essa Pharma Cut to Perform From Outperform by Oppenheimer
Oppenheimer Downgrades ESSA Pharma(EPIX.US) to Hold Rating
Piper Sandler Downgrades ESSA Pharma(EPIX.US) to Hold Rating, Cuts Target Price to $2
ESSA Pharma Downgraded to Hold Amid Masofaniten Trial Termination and Revised Financial Outlook
Essa Pharma Cut to Hold From Buy by Jones Trading
ESSA Pharma Analyst Ratings
JonesTrading Downgrades ESSA Pharma(EPIX.US) to Hold Rating
Oppenheimer Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $17
Oppenheimer Sticks to Their Buy Rating for ESSA Pharma (EPIX)
Piper Sandler Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $15
JonesTrading Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $18
JonesTrading Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $18
Buy Rating Affirmed on ESSA Pharma Amid Promising MCRPC Therapy Data and Upcoming ESMO Conference Insights
Piper Sandler Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $15
Piper Sandler Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $15
ESSA Pharma (EPIX) Receives a Buy From Oppenheimer
Piper Sandler Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $15
No Data